on what basis?
Even if it was 40% discount on current price that is 11.5c. I don't think it would need to be that discounted though.
Assuming this CR price if we needed to raise $8-12M (assuming say $4M to pay for Pfizer debacle and get rid of the BOD and $4 to 8M to continue product development) then based on 11.5c that would be issuing between 70M - 104M new shares or diluting the company a further 8 to 12%.
Yes its a dilution, which isn't ideal, but I would still have skin in the game rather than taking cents in the dollar and then watching Pfizer cash in when our disruptive tech becomes mainstream.
Just my thoughts.
on what basis?Even if it was 40% discount on current price that...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)